Stock listing

OTC:MBVX MabVax Therapeutics Holdings Inc Stock

Follow MabVax Therapeutics Holdings Inc into a list and get an email when it puts out news.

Delisted OTC:MBVX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:MBVX
Asset type
Stock
Exchange
OTC
Currency
USD

MabVax Therapeutics Holdings Inc on 6ix

Decks
17 decks · latest Oct 22, 2018

Where MabVax Therapeutics Holdings Inc is listed

ListingExchangeCountryCurrency
OTC:MBVX · This page · DelistedOTCUnited StatesUSD
OTC:MBVXQ · DelistedOTCUnited StatesUSD

Decks

DeckKindSlidesDate
Investor Presentation (October 2018)Investor deck19 slidesOct 22, 2018
Virtual Investor Conference (May 2018)Conference25 slidesMay 3, 2018
Investor Presentation (February 2018)Investor deck24 slidesFeb 12, 2018
Investor Presentation (September 2017)Investor deck33 slidesSep 12, 2017
Investor Presentation (August 2017)Investor deck33 slidesAug 24, 2017
Investor Presentation (June 2017)Investor deck23 slidesJun 23, 2017
Technical Presentation (April 2017)Technical57 slidesApr 7, 2017
Investor Presentation (March 2017)Investor deck37 slidesMar 31, 2017
Investor Presentation (March 2017)Investor deck57 slidesMar 29, 2017
BIO CEO 2017 Investor ConferenceConference41 slidesFeb 13, 2017
All 17 decks
DeckKindSlidesDate
Investor Presentation (December 2016)Investor deck30 slidesDec 7, 2016
Rodman Conference (September 2016)Conference32 slidesSep 13, 2016
Investor Presentation (September 2016)Investor deck31 slidesSep 6, 2016
Investor Presentation (June 2016)Investor deck30 slidesJun 15, 2016
Investor Presentation (February 2016)Investor deck30 slidesFeb 12, 2016
Investor Presentation (October 2015)Investor deck26 slidesOct 22, 2015
Investor Presentation (May 2015)Investor deck24 slidesMay 27, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert E. Hoffman
Other companies: CytoDyn Inc. (Chief Executive Officer · Since at least May 15, 2025); Esperion Therapeutics, Inc. (Director · Since at least Apr 1, 2025); FibroBiologics, Inc. (Board of Directors · Since at least Jan 24, 2024); TuHURA Biosciences, Inc. (Director · Since at least Apr 11, 2018); Aravive Inc (Director · Oct 12, 2018 – Sep 12, 2019 · Past); Heron Therapeutics, Inc. (CFO & SVP, Finance · Apr 24, 2017 – Dec 19, 2019 · Past); Kura Oncology, Inc. (Director · May 12, 2016 – Jun 22, 2021 · Past); CombiMatrix Corp (Director · May 10, 2016 – Nov 14, 2017 · Past)
Director · Aug 26, 2015 – May 19, 2017 · Past
Jeffrey F Eisenberg
Other companies: Xenetic Biosciences, Inc. (Chief Executive Officer, Director · Nov 1, 2016 – Dec 11, 2023 · Past)
Director · Feb 19, 2016 – Feb 21, 2018 · Past
Gregory P HansonCHIEF FINANCIAL OFFICER, SECR · Dec 16, 2014 – Apr 2, 2018 · Past
Jeffrey V RavetchDirector · Apr 2, 2015 – Jun 12, 2017 · Past
Paul W MaffuidEXEC. VP, R AND D · Dec 31, 2014 – Apr 2, 2018 · Past
Philip O LivingstonCHIEF SCIENCE OFFICER, Director · Apr 4, 2015 – Feb 21, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about MabVax Therapeutics Holdings Inc.